The World Health Organization has issued a grave warning regarding the ongoing Ebola epidemic in the Democratic Republic of Congo. Just two months after the outbreak was officially declared, the latest figures released on July 15 indicate more than 2,000 reported cases, tragically resulting in 796 fatalities. However, a concerning discrepancy has emerged, with the organization suggesting the actual number of individuals infected could be two to four times greater than these official statistics. This raises critical questions: what accounts for this significant disparity, and why has this particular epidemic proven so exceptionally challenging to control? Amidst these concerns, hope emerges with the initiation this week in Bunia of a pioneering clinical trial for post-exposure prophylaxis, a development that could potentially alter the trajectory of this severe health crisis.
